
Zydus Multiple Sclerosis generic receives FDA final nod
New Delhi: Indian drug maker Zydus Lifesciences US-arm has received final approval from the US Food and Drug Administration (FDA) for its multiple sclerosis generic drug ‘Glatiramer Acetate Injection’. The generic version of Copaxone is a single-dose …